Skip to main content
    H

    Humana Inc (HUM)

    Official site

    HEALTHCARE • HEALTHCARE PLANS • NYSE

    $443.43
    -17.82 (-3.86%)

    Market Cap: $55.40B

    Last updated: Nov 17, 2026 at 4:44 PM ET

    Humana Inc (HUM) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Humana (HUM) has a market cap of $55.40B and an enterprise value of $60.97B. Revenue grew 22.02% over the last 12 months from the 12 months before. Its trailing P/E of 33.4x is above its 10-year median of 19.7x.

    Total Valuation

    Enterprise value is 10.05% above the market cap, as debt exceeds cash.

    Market Cap$55.40B
    Enterprise Value$60.97B
    Latest price (Nov 17, 2026)$443.43

    Key Dates

    The next earnings report is expected on Feb 9, 2027, covering the quarter ending Dec 31, 2026. The next ex-dividend date is Dec 24, 2026.

    Next Earnings DateFeb 9, 2027 (expected)
    Last Earnings DateNov 6, 2026
    Next Ex-Dividend DateDec 24, 2026
    Next Payment DateJan 29, 2027
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.02% in the quarter ended Sep 30, 2026 and shrank 0.13% a year over 2 years.

    Shares Outstanding120.10M
    Shares Change (YoY)-0.14%
    Shares Change (QoQ)+0.02%
    Share Count Growth (2Y CAGR)-0.13%

    Valuation Ratios

    Sales and book value multiples are 0.3x and 2.8x. Its year-end P/E ranged from 15.0x to 22.5x from 2016 to 2025.

    P/E Ratio33.4x
    Forward P/E47.0x
    P/S Ratio0.3x
    Forward P/S0.3x
    P/B Ratio2.8x
    P/TBV Ratio6.4x
    P/FCF Ratio17.0x
    P/OCF Ratio14.8x
    PEG Ratio2.3

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 18.0x EBITDA and 18.7x free cash flow.

    EV / Earnings48.3x
    EV / Sales0.4x
    EV / EBITDA18.0x
    EV / EBIT24.3x
    EV / FCF18.7x

    Price Statistics

    The stock is up 89.06% over 52 weeks and trades 8.14% above its 50-day average.

    Beta (1Y)0.54
    52-Week Change+89.06%
    1-Month Change+7.08%
    3-Month Change+17.55%
    6-Month Change+43.12%
    5-Year Change-10.51%
    10-Year Change+141.65%
    Total Return (1Y)+90.57%
    Total Return (3Y CAGR)-2.69%
    Total Return (5Y CAGR)+0.85%
    Return vs SPY (1Y)+79.94%
    Max Drawdown (1Y)-42.36%
    Max Drawdown (3Y)-67.56%
    Sharpe Ratio (1Y)1.39
    Correlation with SPY (1Y)0.16
    50-Day Average$410.04
    200-Day Average$319.10
    52-Week Range$161.56 to $462.87
    RSI (14 Days)58.1
    Average Volume (20 Days)1.56M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.65x current liabilities, and total debt is 0.66x shareholder equity.

    Current Ratio1.65x
    Quick Ratio1.65x
    Debt / Equity0.66x
    Debt / EBITDA3.83x
    Debt / FCF3.98x
    Interest Coverage3.33x

    Returns and Efficiency

    Return on invested capital is 6.06% over the last 12 months, against a 5-year average of 9.17%.

    Return on Equity (ROE)6.70%
    Return on Assets (ROA)2.20%
    Return on Invested Capital (ROIC)6.06%
    Return on Capital Employed (ROCE)7.54%
    ROE (5Y Average)13.21%
    ROA (5Y Average)4.69%
    ROIC (5Y Average)9.17%
    Asset Turnover2.88x
    Receivables Turnover36.02x

    Taxes

    Income tax took 24.20% of pretax income over the last 12 months.

    Income Tax (TTM)$424.00M
    Effective Tax Rate24.20%

    Scores

    HUM has an Altman Z-Score of 4.75, in the safe zone above 2.99, and a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.

    Altman Z-Score4.75
    Altman Z ZoneSafe
    Piotroski F-Score6 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue was $154.19B over the last 12 months.

    Revenue$154.19B
    Revenue Growth (YoY)+22.02%
    Gross Profit$20.06B
    Operating Income$2.38B
    Pretax Income$1.75B
    Net Income$1.26B
    EBITDA$3.27B
    EBIT$2.50B
    Reported EPS (TTM)$13.26

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 32.86% of the $57.28B in total assets.

    Cash and Equivalents$6.93B
    Total Debt$12.50B
    Net Debt$5.57B
    Net Debt Per Share$46.37
    Working Capital$15.56B
    Shareholder Equity$18.82B
    Book Value Per Share$156.74
    Tangible Book Value$8.28B
    Tangible Book Per Share$68.92
    Total Assets$57.28B
    Total Liabilities$38.40B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $592.00M of capital spending, operating cash flow left $3.14B of free cash flow.

    Operating Cash Flow$3.73B
    Capital Expenditures$592.00M
    Free Cash Flow$3.14B
    FCF Per Share$26.14
    Depreciation and Amortization$763.00M
    Dividends Paid$429.00M
    Share Repurchases$152.00M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 1.54%, against a 5-year average of 3.18%.

    Gross Margin13.01%
    Operating Margin1.54%
    Pretax Margin1.14%
    Net Margin0.82%
    EBITDA Margin2.12%
    EBIT Margin1.62%
    FCF Margin2.04%
    Gross Margin (5Y Average)16.23%
    Operating Margin (5Y Average)3.18%
    Net Margin (5Y Average)2.17%

    Growth

    Revenue grew 11.77% a year over 3 years, and EPS fell 12.09% a year.

    Revenue Growth (3Y CAGR)+11.77%
    Revenue Growth (5Y CAGR)+10.94%
    EPS Growth (3Y CAGR)-12.09%
    EPS Growth (5Y CAGR)-1.78%
    FCF Growth (3Y CAGR)-52.28%
    FCF Growth (5Y CAGR)-39.63%
    Operating Income Growth (3Y CAGR)-10.72%
    Book Value Per Share Growth (2Y CAGR)+5.12%
    Tangible Book Per Share Growth (2Y CAGR)+9.93%

    Revenue and profit by year

    Dividends and Yields

    HUM pays out 11.40% of earnings as dividends.

    Dividend Per Share (Annual)$3.54
    Dividend Yield0.80%
    Payment ScheduleQuarterly
    Dividend Growth (3Y CAGR)+3.97%
    Dividend Growth (5Y CAGR)+7.20%
    Payout Ratio11.40%
    FCF Payout Ratio13.67%
    Earnings Yield2.99%
    FCF Yield5.89%
    Buyback Yield0.29%
    Shareholder Yield1.09%

    Full dividend history

    Peer Position

    Against 12 similar companies, HUM has the 4th highest P/E and the 7th highest P/S.

    P/E Ratio33.4x vs 16.7x median
    P/S Ratio0.3x vs 0.4x median
    ROIC6.06% vs 9.34% median
    Revenue Growth (Trailing 4 Quarters, YoY)+22.02% vs +7.15% median
    Dividend Yield0.80% vs 0.41% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 15.70% and EPS growth at 2.95% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+15.70%
    EPS Growth Forecast (2Y CAGR)+2.95%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About HUM

    What is HUM's market cap?

    Humana has a market cap of $55.40B. Its enterprise value, which adds debt and subtracts cash, is $60.97B.

    What is HUM's P/E ratio?

    Humana has a trailing P/E ratio of 33.4x and a forward P/E of 47.0x.

    How many shares of HUM are outstanding?

    Humana has 120.10M shares outstanding. The count is down 0.14% from a year earlier.

    Does HUM pay a dividend?

    Yes. Humana pays $3.54 a share a year, a dividend yield of 0.80%.

    How much debt does HUM have?

    Humana has $12.50B of total debt and $6.93B of cash and equivalents, a net debt position of $5.57B.